Scientific Sessions 2025  /  Transformative Advances in Genome Engineering for Precision Therapy  /  Ethical considerations of gene editing technologies
Logo

American Heart Association

  35
  0

Final ID:

Ethical considerations of gene editing technologies

  • Magnus, David  ( Stanford , California , California , United States )
  • Tabort, Holly  ( Stanford , California , California , United States )
  • Saha, Krishanu  ( University of Wisconsin , Madison , Wisconsin , United States )
    • Author Disclosures:
    david magnus: No Answer | Holly Tabort: DO NOT have relevant financial relationships | Krishanu Saha: DO have relevant financial relationships ; Advisor:Bharat Biotech:Active (exists now) ; Advisor:Notch Therapeutics:Past (completed) ; Advisor:Andson Biotech:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Transformative Advances in Genome Engineering for Precision Therapy

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
RNA editing: a tractable future therapeutic?

Weldy Chad, Gan Li-ming, Stafforst Thorsten

Treating cardiovascular disease with Base and Prime Editing

Seidman Christine, Steinmetz Lars, Olson Eric

You have to be authorized to contact abstract author. Please, Login
Not Available